Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
View Patent ↗The present invention is based on the discovery of genetic polymorphisms that are associated with rheumatoid arthritis. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.
1. A method of determining whether a human has an increased risk for RF-positive rheumatoid arthritis, comprising:
a) detecting in nucleic acid from said human the presence of at least one T allele at a polymorphism in the PTPN22 gene at position 101 of SEQ ID NO: 36673, or at least one A allele at position 101 of the complement of SEQ ID NO: 36673; and
b) correlating the presence of said T allele or said A allele with said human having said increased risk for RF-positive rheumatoid arthritis.
2. The method of claim 1 , wherein said correlating is performed by computer software.
3. The method of claim 1 , wherein said nucleic acid is a nucleic acid extract from a biological sample from said human.
4. The method of claim 3 , wherein said biological sample is blood, saliva, or buccal cells.
5. The method of claim 3 , further comprising preparing said nucleic acid extract from said biological sample prior to said detecting.
6. The method of claim 5 , further comprising obtaining said biological sample from said human prior to said preparing.
7. The method of claim 1 , wherein said detecting comprises nucleic acid amplification.
8. The method of claim 7 , wherein said nucleic acid amplification is carried out by polymerase chain reaction.
9. The method of any one of claims 1 to 8 , wherein said detecting is performed using sequencing, 5′ nuclease digestion, molecular beacon assay, oligonucleotide ligation assay, size analysis, single-stranded conformation polymorphism analysis, or denaturing gradient gel electrophoresis (DGGE).
10. The method of any one of claims 1 to 8 , wherein said detecting is performed using an allele-specific method.
11. The method of claim 10 , wherein said allele-specific method is allele-specific probe hybridization, allele-specific primer extension, or allele-specific amplification.
12. The method of claim 10 , wherein said allele-specific method detects said T allele or said A allele.
13. The method of claim 1 which is an automated method.
14. The method of claim 1 wherein said human is homozygous for said T allele or said A allele.
15. The method of claim 1 wherein said human is heterozygous for said T allele or said A allele.
16. The method of claim 1 , wherein said detecting is performed using at least one detection reagent selected from the group consisting of detection reagents comprising the nucleotide sequences of SEQ ID NO: 49745, SEQ ID NO: 49746, and SEQ ID NO: 49747.
17. The method of claim 1 , further comprising providing a report of the identity of said polymorphism.
18. The method of claim 1 , further comprising providing a report of said human's risk for developing RF-positive rheumatoid arthritis.
19. The method of claim 18 , wherein the report further shows the identity of said polymorphism.
20. The method of claim 17 , wherein the report is computer readable medium form.